Shots:

• Qiagen’s QIAstat-Dx and NeuMoDx tests remain accurate & effective in detecting SARS-CoV-2 infections
• The company started cross-checking variants in May’2020 & assessed the tests against genetic mutations of the virus uploaded to the GISAID and GenBank public databases. Qiagen will continue to conduct assessments on a biweekly basis
• Variants with potentially increased transmissibility include VUI 202012/01 (detected in the UK)- 501Y.V2 (identified in South Africa)- and B.1.1.28 P1 (discovered in Brazil)

 ­ Ref: PRNewswire | Image: Qiagen